Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.34 USD
-0.19 (-7.51%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.34 0.00 (0.00%) 6:28 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: AMC |
3/2024 | $-0.11 | -9.09% |
Earnings Summary
For their last quarter, Taysha Gene Therapies (TSHA) reported earnings of $0.35 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 488.89%. Look out for TSHA's next earnings release on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 60.71%.
Earnings History
Price & Consensus
Zacks News for TSHA
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services